CZC 25146

Pricing Availability   Qty
说明: Potent LRRK2 inhibitor
化学名: N-[2-[[5-Fluoro-2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]amino]phenyl]methanesulfonamide
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for CZC 25146

CZC 25146 is a potent LRRK2 inhibitor (IC50 values are 4.76 and 6.87 nM for for wild-type and G2019S mutant forms of LRRK2, respectively). Also inhibits PLK4, GAK, TNK1, CAMKK2 and PIP4K2. Attenuates mutant LRRK2-induced injury of cultured rodent and human neurons. Cell permeable.

化合物库 for CZC 25146

CZC 25146 is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Kinase Inhibitor Library. 了解 Tocris 化合物库的更多信息。

技术数据 for CZC 25146

分子量 488.54
公式 C22H25FN6O4S
储存 Store at -20°C
纯度 ≥98% (HPLC)
CAS Number 1191911-26-8
PubChem ID 44252884
InChI Key XXHHOTZUJIXPJX-UHFFFAOYSA-N
Smiles FC1=C(NC2=CC=CC=C2NS(C)(=O)=O)N=C(NC3=C(OC)C=C(N4CCOCC4)C=C3)N=C1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

溶解性数据 for CZC 25146

溶剂 最高浓度 mg/mL 最高浓度 mM
溶解性
DMSO 48.85 100

制备储备液 for CZC 25146

以下数据基于产品分子量 488.54。 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

选择批次从而根据批次分子量重新计算:
浓度/溶剂体积/质量 1 mg 5 mg 10 mg
1 mM 2.05 mL 10.23 mL 20.47 mL
5 mM 0.41 mL 2.05 mL 4.09 mL
10 mM 0.2 mL 1.02 mL 2.05 mL
50 mM 0.04 mL 0.2 mL 0.41 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

产品说明书 for CZC 25146

分析证书/产品说明书
选择另一批次:

参考文献 for CZC 25146

参考文献是支持产品生物活性的出版物。

Ramsden et al (2011) Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neurons. ACS Chem.Biol. 6 1021 PMID: 21812418


If you know of a relevant reference for CZC 25146, please let us know.

按产品操作查看相关产品

查看全部 LRRK2 Inhibitors

关键词: CZC 25146, CZC 25146 supplier, CZC25146, leucine-rich, repeat, kinase, 2, LRRK2, inhibitors, inhibits, potent, neuroprotective, neuronal, injury, parkinson's, parkinsons, 6071, Tocris Bioscience

篇 CZC 25146 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 CZC 25146 的引用文献。 您是否知道使用了 Tocris CZC 25146 的优秀论文? 请告知我们.

CZC 25146 的评论

目前没有该产品的评论。 Be the first to review CZC 25146 and earn rewards!

Have you used CZC 25146?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.